ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

12,050.00
-106.00 (-0.87%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -106.00 -0.87% 12,050.00 12,036.00 12,038.00 12,178.00 12,010.00 12,092.00 1,635,146 16:35:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.34 186.61B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,156p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,266.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £186.61 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.34.

Astrazeneca Share Discussion Threads

Showing 4901 to 4919 of 6150 messages
Chat Pages: Latest  198  197  196  195  194  193  192  191  190  189  188  187  Older
DateSubjectAuthorDiscuss
25/5/2021
14:53
So what's Biden said now ? :-S
philanderer
25/5/2021
14:48
AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p
philanderer
25/5/2021
14:10
I'd have thought AZN would have had a nod and a wink before going for this deal.
philanderer
23/5/2021
00:16
Covid: Pfizer and AstraZeneca jabs effective against Indian variant - study
philanderer
22/5/2021
15:47
EU's actions may have damaged the Oxford vaccine take up in EU yet other countries are willing to put their faith in the vaccine. The court will judge the facts but the court of the people could have already decided EU have a case to answer re damaging the vaccine safety protocol to hide poor leadership, etc?
stutes
21/5/2021
16:31
don't know about monty's but Farallon Capital Management, L.L.C.'s shorts are well on fire, increased to 0.60% of shares in issue 4 weeks ago. Ha!
nerdlinger
21/5/2021
10:58
Two doses of the AstraZeneca Covid-19 vaccine provide between 85% and 90% protection from symptomatic disease, according to a study from Public Health England.


Bloomberg

philanderer
21/5/2021
07:35
Japan's approval of the COVID 19 vaccine is good news given the European backdrop.
our haven
21/5/2021
06:07
chartwise AZN m now looks quite good for a further move upwards
arja
20/5/2021
17:13
Montys shorts are well on fire now.
freddie ferret
20/5/2021
15:57
I see Alexion is over $175 per adr - yet AZN remains below £86 per share.
stutes
12/5/2021
12:28
In one way the CEO's pay is, in my opinion, a deliver or be sacked for under performing ultimatum; interestingly the ultimatum being set by the Board.
stutes
12/5/2021
09:56
The Alexion deal received shareholders' approval. The drop in the share price, initially put down to the price and fears over integration, remains in part.

I think it could take a few quarters before the City warms to the deal?

stutes
10/5/2021
16:36
Firstly I accept executive pay should be fair. What I don't accept, if a company buys another then pay shouldn't go up to reflect a bigger business - if an executive works 12hrs for the firm buying the company, after the merger does it mean the executive has to work 15 hrs+ day , more than likely executive(s) are appointed to take the burden off the CEO.
stutes
10/5/2021
15:08
If Alexion needs AZN to bankroll its pipeline then the balance of power is with AZN - AZN doesn't need to buy 100% of Alexion but a smaller % and access to the future pipeline.
stutes
09/5/2021
14:26
Live Coronavirus latest news: Europe will not renew order for extra AstraZeneca vaccine doses


Sarah Newey, global health security correspondent Ewan Somerville
9 MAY 2021 • 2:13PM




The European Commission has not renewed its order for AstraZeneca vaccines beyond June, amid legal disputes and a pivot towards the Pfizer jab.

According to the European Internal Market Commissioner, Thierry Breton, Europe will not order additional doses of the Oxford-AstraZeneca jab moving forward. The European Commission could have triggered a clause for additional 100 million doses of the vaccine.

"We did not renew the order after June. We’ll see what happens," said Breton, adding that it was "a very good vaccine".

Such a move is not unexpected amid fraught relations. Last month the Commission launched legal action against AstraZeneca for not respecting its contract for the supply of Covid-19 vaccines and for not having a "reliable" plan to ensure timely deliveries.

And this week the bloc cemented its desire to use the Pfizer-BioNTech for the bulk of its rollout moving forward. Yesterday, the European Commission agreed to a massive contract extension for a potential 1.8 billion doses of the mRNA vaccine through 2023.

Commission President, Ursula von der Leyen, said her office has approved a contract for a guaranteed 900 million doses with the same amount of doses as a future option.

The new agreement, which has the unanimous backing of the 27 EU member nations, will entail not only the production of the vaccines but also making sure that all the essential components are sourced from the EU.

Meanwhile the head of the Oxford University vaccine group urged wealthy countries, including the UK, to share available vaccines with the rest of the world before pursuing plans to offer citizens booster shots.

"We're facing an absolute calamity," Prof Pollard told BBC, pointing to research which shows that around 30,000 people around the world will die from Covid-19 today alone.

maxk
08/5/2021
15:36
FF,

Lol! Have a good weekend.

beckers2008
08/5/2021
01:01
Interesting how the posting rate has dropped right off.

Maybe it is just that nutters have appeared? (not you Beckers).

freddie ferret
07/5/2021
09:42
AstraZeneca: 06/05/21 - Liberum reiterates buy with a target price of 9,220p
beckers2008
Chat Pages: Latest  198  197  196  195  194  193  192  191  190  189  188  187  Older

Your Recent History

Delayed Upgrade Clock